A group of patients with a binge-eating disorder were randomly assigned to take either the experimental drug fluvoxamine or a placebo in a 9-week long double-blind clinical trial. At the end of the trial the condition of each patient was classified into one of four categories: no response, moderate response, marked response, or remission. The following table shows a cross classification of the data. Is there statistically significant evidence, at the 0.10 level, to conclude that there is an association between treatment group (fluvoxamine versus placebo) and condition?

Transcribed Image Text:

No response Moderate response Marked response Remission Total Fluvoxamine Placcbo Total 43 14